Table 4:
One year of therapy with the COMB protocol compared to strontium ranelate and bisphosphonate medications.
Percent change
COMB protocol: one year whole group (postmenopausal females)
Comparison to Strontium Ranelate at one year [
21
]
Comparison to Alendronate at one year [
44
]
Comparison to Risedronate at one year [
45
]
Femoral neck
4%
2%
2%
2%
Total hip
3%
3-4%
2%
Not calculated
Lowest hip site
4%
Not calculated
Not calculated
Not calculated
Total spine
6%
5-6%
4%
4%
Lowest spine site
8%
Not calculated
Not calculated
Not calculated